“Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy As a Medically Treatable Disease”. Journal of Heart and Cardiovascular Science, vol. 3, no. 1, Oct. 2022, pp. 16-21, https://doi.org/10.5281/zenodo.22344598.